Professor, Internal Medicine, University of Texas Medical School, Houston

Rheumatology

John Reveille practices Rheumatology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is one of the top medical schools in the US. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 2 awards "Top Doctors:SE Texas" and "Super Doctor". Doctor John D. Reveille, MD has written publications. He has 99 publications published with PubMed. The lastest publication is: 'Response to "Comment on the Recommendations by Ward et al for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis" by Akkoc and Khan.' He accepts all Medicare patients.

Publications

---

• American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosi...
• Prevalence of chronic axial pain, inflammatory back pain and spondyloArthritis in diagnosed psoriasis.
• Antinuclear antibody-negative systemic sclerosis.
• The Concept of Axial SpondyloArthritis: SPARTAN and ASAS joint Statement in response to FDA's comments and concerns.
• The relationship between blood IL-12p40 level and melanoma progression.
• Major histocompatibility complex (MHC) class I and II alleles which confer susceptibility or protection in the Morphea in Adults and Children (MAC) cohort.
• Preferential association of a functional variant in complement receptor 2 with antibodies to double-stranded DNA.
• The IRF5-TNPO3 association with systemic Lupus erythematosus (SLE) has two components that other autoimmune disorders variably share.
• Brief Report: A Polymorphism in TLR2 Is Associated With Arterial Thrombosis in a Multiethnic Population of Patients With Systemic Lupus Erythematosus.
• Role of PPM1A and anti-PPM1A Autoantibodies in Ankylosing Spondylitis.
• Fcγ Receptor IIIa Single-Nucleotide Polymorphisms and Haplotypes Affect Human IgG Binding and Are Associated With Lupus Nephritis in African Americans.
• An update on the contribution of the MHC to as susceptibility.
• Two Functional Lupus-Associated BLK Promoter Variants Control Cell-Type- and Developmental-Stage-Specific Transcription.
• End-Stage Renal Disease in African Americans With Lupus Nephritis Is Associated With APOL1.
• Effects of statins on proinflammatory/prothrombotic biomarkers and on Disease activity scores in SLE patients: data from LUMINA (LXXVI), a multi-ethnic US cohort.
• Immunochip analysis identifies multiple susceptibility Loci for systemic sclerosis.
• Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis.
• Allelic-dependent expression of an activating fc receptor on B Cells enhances humoral immune responses.
• FcγRIIIa SNPs and haplotypes affect human IgG binding and association with Lupus nephritis in African Americans.
• Preferential binding to Elk-1 by SLE-associated IL10 risk allele upregulates IL10 expression.
• End-stage kidney Disease in African Americans with lupus nephritis associates with APOL1.
• Value of isolated IgA anti-β2 GPI positivity in the diagnosis of the Antiphospholipid syndrome.
• Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid Arthritis: consequences of low adherence.
• The epidemiology of back pain, axial spondyloArthritis and HLA-B27 in the United States.
• MICA, a gene contributing strong susceptibility to Ankylosing spondylitis.
• A registry of Ankylosing spondylitis registries and prospects for global interfacing.
• Variable Association of Reactive Intermediate Genes with Systemic Lupus Erythematosus in Populations with Different African Ancestry.
• Functional limitations due to axial and peripheral joint impairments in patients with Ankylosing spondylitis: are focused measures more informative?
• Fine mapping of Xq28: both MECP2 and IRAK1 contribute to risk for systemic Lupus erythematosus in multiple ancestral groups.
• The prevalence of inflammatory back Pain: population-based estimates from the US National Health and Nutrition Examination Survey, 2009-10.
• MicroRNA-3148 Modulates Allelic Expression of Toll-Like Receptor 7 Variant Associated with Systemic Lupus Erythematosus.
• Regional radiographic damage and functional limitations in patients with Ankylosing spondylitis: Differences in early and late disease.
• C-reactive protein predictsthe long-term progression of interstitial lung Disease and survival in patients with early systemic sclerosis.
• Admixture Mapping in Lupus Identifies Multiple Functional Variants within IFIH1 Associated with Apoptosis, Inflammation, and Autoantibody Production.
• Brief Report: Single-nucleotide polymorphisms in VKORC1 are risk factors for systemic Lupus erythematosus in Asians.
• Two independent functional risk haplotypes in TNIP1 are associated with systemic Lupus erythematosus.
• Impact of genetic ancestry and socio-demographic status on the clinical expression of systemic Lupus erythematosus in Amerindian-European populations.
• Correlation of interferon-inducible chemokine plasma levels with Disease severity in systemic sclerosis.
• Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and Disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort.
• Measuring therapeutic adherence in systemic Lupus erythematosus with electronic monitoring.
• Genetics of spondyloArthritis-beyond the MHC.
• IRF5 polymorphism predicts prognosis in patients with systemic sclerosis.
• Evidence for gene-gene epistatic interactions among susceptibility loci for systemic Lupus erythematosus.
• Is there a higher genetic load of susceptibility loci in familial Ankylosing spondylitis?
• Association of Discoid lupus with clinical manifestations and damage accrual in profile: A multiethnic lupus cohort.
• The prevalence of HLA-B27 in the United States: Data from the U.S. National Health and Nutrition Examination Survey, 2009.
• IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with sys...
• Identification of novel genetic susceptibility loci in African American Lupus patients in a candidate gene association study.
• The contribution of disease activity on functional limitations over time through psychological mediators: a 12-month longitudinal study in patients with Ankylosing spo...
• Novel multiplex technology for diagnostic characterization of rheumatoid Arthritis.
• Anti-Fibrillarin Antibody in African American Patients with Systemic Sclerosis: Immunogenetics, Clinical Features, and Survival Analysis.
• Prologue: 2010 SpondyloArthritis Research and Therapy Network (SPARTAN) annual research and education meeting.
• Epidemiology of spondyloArthritis in North America.
• Genetic analyses of interferon pathway-related genes reveals multiple new loci associated with systemic Lupus erythematosus (SLE).
• HLA-DRB1*0407 and *1304 are risk factors for scleroderma renal crisis.
• Ankylosing spondylitis: patterns of radiographic involvement--a re-examination of accepted principles in a cohort of 769 patients.
• A novel statistic for genome-wide interaction analysis.
• The genetics of scleroderma (systemic sclerosis).
• Systemic sclerosis and Lupus: points in an interferon-mediated continuum.
• Development and validation of a case ascertainment tool for Ankylosing spondylitis.
• The role of genetic variation near interferon-kappa in systemic Lupus erythematosus.
• HLA-DPB1 and DPB2 are genetic loci for systemic sclerosis: a genome-wide association study in Koreans with replication in North Americans.
• Polymorphisms in TBX21 and STAT4 increase the risk of systemic sclerosis: evidence of possible gene-gene interaction and alterations in Th1/Th2 cytokines.
• A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic Lupus erythematosus.
• Clinical and genetic factors predictive of mortality in early systemic sclerosis.
• Recent studies on the genetic basis of Ankylosing spondylitis.
• Disease activity and damage are not associated with increased levels of fatigue in systemic lupus erythematosus patients from a multiethnic cohort: LXVII.
• Ultraviolet radiation intensity predicts the relative distribution of Dermatomyositis and anti-Mi-2 autoantibodies in women.
• A polymorphism within IL21R confers risk for systemic Lupus erythematosus.
• Clinical and immunogenetic prognostic factors for radiographic severity in Ankylosing spondylitis.
• Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era.
• Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort.
• High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic Lupus erythematosus in different racial groups.
• Variants within MECP2, a key transcription regulator, are associated with increased susceptibility to Lupus and differential gene expression in patients with systemic ...
• SpondyloArthritis: clinical suspicion, diagnosis, and sports.
• Subtypes of HLA-B27: history and implications in the pathogenesis of Ankylosing spondylitis.
• Therapy insight: the changing spectrum of rheumatic Disease in HIV infection.
• Klinefelter's Syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome.
• The contribution of genes outside the major histocompatibility complex to susceptibility to Ankylosing spondylitis.
• Occupational physical activities and long-term functional and radiographic outcomes in patients with Ankylosing spondylitis.
• Impact of Ankylosing spondylitis on work and family life: comparisons with the US population.
• Women with Ankylosing spondylitis: a review.
• Systemic Lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausa...
• Clinical, immunologic, and genetic features of familial systemic sclerosis.
• Pulmonary involvement in systemic sclerosis: associations with genetic, serologic, sociodemographic, and behavioral factors.
• Association of a TNAP haplotype with Ankylosing spondylitis.
• HLA polymorphisms in African Americans with idiopathic inflammatory myopathy: allelic profiles distinguish patients with different clinical phenotypes and myositis aut...
• The genetic basis of Ankylosing spondylitis.
• Trust in physicians and elements of the medical interaction in patients with rheumatoid Arthritis and systemic lupus erythematosus.
• Changing spectrum of the diffuse infiltrative lymphocytosis Syndrome.
• Systemic lupus erythematosus in a multiethnic US cohort: XXXVI. Influence of mannose-binding lectin exon 1 polymorphisms in Disease manifestations, course, and outcome.
• Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1, and -DQA1 allelic profiles distinguish European A...
• Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clini...
• Risk factors for functional limitations in patients with long-standing Ankylosing spondylitis.
• Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
• Seasonal influence on the onset of idiopathic inflammatory myopathies in serologically defined groups.
• Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXI. Disease activity, damage accrual, and vascular events in pre- and postmenopausal women.
• Response to "Comment on the Recommendations by Ward et al for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis" by Akkoc and Khan.

Schools

---

• Johns Hopkins University School Of Medicine

• University Miami Affil Hosps

• Johns Hopkins

Procedures Preformed

---

• Joint Drainage
• Myofascial Trigger Point Injection
• Steroid Injection
• Trigger Point Injection

Conditions Treated

---

• Achilles Tendinitis
• Adhesive Capsulitis
• Ankylosing Spondylitis
• Antiphospholipid Syndrome (APS)
• View All

Doctors Specialties

---

• Rheumatology

Accepted Insurances

---

Awards

---

• Top Doctors:SE Texas
• Super Doctor

Education

---

• Johns Hopkins University
• Jackson Memorial Hospital - Jackson Health System
• Johns Hopkins University School of Medicine

Drug Facts

---

NPI NUMBER		1295753408
NPPES Provider LastName		REVEILLE
NPPES Provider FirstName		JOHN
NPPES Provider ZIPCode		770303000
NPPES Provider State		TX
Specialty Description		Rheumatology
Total Claim Count		451.0
Distinct Opioid Count		2.0
Opioid Claim Count		63.0
Percent Opioid Claims		13.97

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1295753408
Last Name Of The Provider	REVEILLE
First Name Of The Provider	JOHN
View All

Similar Doctors

---

	Dr. Maureen D. Mayes, MD This Doctor is OpenDoctor Recommended.
	Dr. David E. Burns, MD This Doctor is OpenDoctor Recommended.
	Dr. Emily W. Hung, MD
	Dr. Sean X. Tao, MD This Doctor is OpenDoctor Recommended.
	Dr. Alexandra M. Gonzalez-Fuentes, MD
	Dr. Oluyemisi O. Awobokun, MD This Doctor is OpenDoctor Recommended.
	Dr. Sheila M. Albuquerque, MD This Doctor is OpenDoctor Recommended.
	Dr. Serge De Golovine, MD
	Dr. Noranna B. Warner, MD This Doctor is OpenDoctor Recommended.
	Dr. Qaiser Rehman, MD This Doctor is OpenDoctor Recommended.
	Dr. Hema Salvady, MD This Doctor is OpenDoctor Recommended.
	Dr. Gineth P. Pinto-Patarroyo, MD This Doctor is OpenDoctor Recommended.
	Dr. John I. Gomez, MD This Doctor is OpenDoctor Recommended.
	Dr. Tareq A. Abou Khamis, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah Bourgeois, MD
	Dr. Gabriela Nicola, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog